Blogs

Hims & Hers GLP-1 pill gambit backfires, accelerating crackdown on drug compounders

By NADDI Admin posted 2 days ago

  

Online telehealth company Hims & Hers Health (HIMS.N), opens new tab, seeking growth drivers as its original sexual-health franchises matured, may have overstepped with a risky launch of weight-loss pills that drew swift blowback from Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab and U.S. regulators.

Read Article

#GLP-1

#Compounding

0 comments
0 views

Permalink